cardiovascular disease

Health Elaine Chen

STAT Plus: Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles

Pharma Elaine Chen

STAT Plus: Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label

In the Lab Elaine Chen

Microplastics found in blood vessels linked to greater risk of heart problems, study finds

Letters to the editor Torie Bosch

What STAT readers think about octogenarian presidents

Health Annalisa Merelli

Niacin has long been a public health darling. But an excess could be bad for the heart, study suggests

Health tech Mario Aguilar

STAT Plus: Digital tools helped lower blood pressure in marginalized patient groups

First Opinion Arthur L. Kellermann

The health care system is ignoring world’s most promising approach to preventing cardiovascular disease

Health tech Lizzy Lawrence

STAT Plus: FDA advisory panel votes in favor of Abbott’s new heart device

Health Elaine Chen

Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease

Business Tara Bannow

STAT Plus: Lasers, cardiology, clinical trials: 2023’s top private equity targets

Biotech Damian Garde

STAT Plus: At JPM, Verve details plot to take genome editing mainstream

Health Gina Ryder

Cardiac psychologists are pushing to protect heart patients’ often-overlooked mental health

Health Elaine Chen

STAT Plus: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds

Health Elaine Chen

People with congenital heart disease are living longer — but facing new threat of heart failure

Health tech Lizzy Lawrence

STAT Plus: FDA approves Medtronic high blood pressure device despite a negative advisory panel vote

Biotech Matthew Herper

STAT Plus: Eli Lilly’s chief scientist on new obesity drug data, gene editing, and a potential new heart drug

Pharma Elaine Chen

STAT Plus: Novo Nordisk wants to be a cardiovascular company, too, with sights set on inflammation

Biotech Elaine Chen

STAT Plus: Anthos stroke drug appears safer than common blood thinner in mid-stage trial

Health Matthew Herper

STAT Plus: After decades in use, heart stents finally beat placebo. It took a bold researcher

Pharma Elaine Chen

STAT Plus: Wegovy cuts risk of heart attacks in milestone cardiovascular trial

Health tech Lizzy Lawrence

STAT Plus: FDA approves high blood pressure device from Recor Medical

Health Deborah Balthazar

Second recipient of genetically modified pig heart dies, six weeks after surgery

Health Theresa Gaffney

Extreme heat could lead to 233% increase in U.S. excess cardiovascular deaths, study says

Health tech Lizzy Lawrence

STAT Plus: Boston Scientific’s drug-coated balloon may reduce risk of heart attack

Health Isabella Cueto

The cardiologist building digital tools to help colleagues stay on top of new research

Health Annalisa Merelli and Matthew Herper

STAT Plus: A controversial new study examines traditional Chinese medicine’s potential cardiac benefits

Politics John Wilkerson

STAT Plus: When Medicare paid doctors differently, fewer patients had heart problems

Health tech Lizzy Lawrence

STAT Plus: FDA’s warning to J&J’s Abiomed signals a crackdown on digital health tools

Health Elaine Chen

Stroke deaths, despite advances in prevention, are set to near 10 million globally by 2050